Keyphrases
Primary Afferent
100%
Antinociception
100%
Isobolographic Analysis
100%
Pharmacological Profile
100%
α2-adrenergic Agonist
100%
Genetically Engineered Mice
100%
Dexmedetomidine
50%
Circuitry
50%
Opioid Receptors
50%
Central Nervous System
50%
Analgesic
50%
Antinociceptive
50%
Inhibitory Control
50%
Distribution Pattern
50%
Supraspinal
50%
Nociceptive Neurons
50%
Spinal Dorsal Horn Neurons
50%
Opioid Agonist
50%
Receptor Subtypes
50%
Adrenergic Receptors
50%
Specific Interactions
50%
Noradrenergic
50%
Clonidine
50%
Moxonidine
50%
Spinal Level
50%
α2-adrenergic Receptor
50%
Pain Signaling
50%
Brimonidine
50%
Spinal Afferent
50%
Anatomical Description
50%
GPCR Agonists
50%
Medicine and Dentistry
Antinociception
100%
Alpha 2 Adrenergic Receptor Stimulating Agent
100%
Central Nervous System
50%
G Protein Coupled Receptor
50%
Horn
50%
Side Effect
50%
Alpha 2 Adrenergic Receptor
50%
Opiate Agonist
50%
Receptor Subtype
50%
Clonidine
50%
Brimonidine
50%
Dexmedetomidine
50%
Adrenergic Receptor
50%
Moxonidine
50%
Opioid Receptor
50%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha 2 Adrenergic Receptor Stimulating Agent
100%
Antinociception
100%
Opiate Receptor
50%
Side Effect
50%
Analgesic Agent
50%
Adrenergic Receptor
50%
Opiate Agonist
50%
Alpha 2 Adrenergic Receptor
50%
Receptor Subtype
50%
Clonidine
50%
G Protein Coupled Receptor
50%
Moxonidine
50%
Dexmedetomidine
50%
Brimonidine
50%
Neuroscience
Alpha-2 Adrenergic Receptor
100%
Agonist
100%
Sympathomimetic Drug
100%
Central Nervous System
20%
Moxonidine
20%
Dexmedetomidine
20%
Brimonidine
20%
Receptor Subtype
20%
Adrenergic Receptor
20%
G Protein Coupled Receptor
20%
Receptor
20%
Clonidine
20%